Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

PLoS One. 2013 May 16;8(5):e64217. doi: 10.1371/journal.pone.0064217. Print 2013.

2.

Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.

Chatterjee S, Chen H, Johnson ML, Aparasu RR.

Am J Geriatr Pharmacother. 2012 Apr;10(2):83-94. doi: 10.1016/j.amjopharm.2011.10.006. Epub 2012 Feb 10.

PMID:
22306198
4.

Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?

Rossom RC, Rector TS, Lederle FA, Dysken MW.

J Am Geriatr Soc. 2010 Jun;58(6):1027-34. doi: 10.1111/j.1532-5415.2010.02873.x. Epub 2010 May 7.

PMID:
20487081
5.

Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

J Clin Psychopharmacol. 2013 Feb;33(1):24-30. doi: 10.1097/JCP.0b013e31827934a4.

PMID:
23277238
6.

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

Marras C, Herrmann N, Anderson GM, Fischer HD, Wang X, Rochon PA.

Am J Geriatr Pharmacother. 2012 Dec;10(6):381-9. doi: 10.1016/j.amjopharm.2012.11.001.

PMID:
23217531
7.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
8.

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC.

JAMA Psychiatry. 2015 May;72(5):438-45. doi: 10.1001/jamapsychiatry.2014.3018.

9.

Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.

Prabhakar M, Haynes WG, Coryell WH, Chrischilles EA, Miller del D, Arndt S, Ellingrod VL, Warren L, Fiedorowicz JG.

Pharmacotherapy. 2011 Aug;31(8):806-12. doi: 10.1592/phco.31.8.806.

10.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Asmal L, Flegar SJ, Wang J, Rummel-Kluge C, Komossa K, Leucht S.

Cochrane Database Syst Rev. 2013 Nov 18;(11):CD006625. doi: 10.1002/14651858.CD006625.pub3. Review.

PMID:
24249315
11.
12.

Quetiapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, Srisurapanont M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006625. doi: 10.1002/14651858.CD006625.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD006625.

13.

Diabetes risk associated with use of olanzapine, quetiapine, and risperidone in veterans health administration patients with schizophrenia.

Lambert BL, Cunningham FE, Miller DR, Dalack GW, Hur K.

Am J Epidemiol. 2006 Oct 1;164(7):672-81. Epub 2006 Aug 30.

PMID:
16943266
14.

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.

Yoon HJ, Park KM, Choi WJ, Choi SH, Park JY, Kim JJ, Seok JH.

BMC Psychiatry. 2013 Sep 30;13:240. doi: 10.1186/1471-244X-13-240.

15.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
16.

Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.

Olfson M, Gerhard T, Huang C, Lieberman JA, Bobo WV, Crystal S.

Schizophr Bull. 2012 Jun;38(4):845-53. doi: 10.1093/schbul/sbq172. Epub 2011 Feb 9.

17.

Antipsychotics and mortality in Parkinsonism.

Marras C, Gruneir A, Wang X, Fischer H, Gill SS, Herrmann N, Anderson GM, Hyson C, Rochon PA.

Am J Geriatr Psychiatry. 2012 Feb;20(2):149-58. doi: 10.1097/JGP.0b013e3182051bd6.

PMID:
22273735
18.

Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.

Pasternak B, Svanström H, Ranthe MF, Melbye M, Hviid A.

CNS Drugs. 2014 Oct;28(10):963-73. doi: 10.1007/s40263-014-0176-0.

PMID:
24895158
19.

Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

Dossenbach M, Pecenak J, Szulc A, Irimia V, Anders M, Logozar-Perkovic D, Peciukaitiene D, Kotler M, Smulevich AB, West TM, Lowry AJ, Treuer T.

J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.

PMID:
19012820
20.

Risk of mortality among individual antipsychotics in patients with dementia.

Kales HC, Kim HM, Zivin K, Valenstein M, Seyfried LS, Chiang C, Cunningham F, Schneider LS, Blow FC.

Am J Psychiatry. 2012 Jan;169(1):71-9. doi: 10.1176/appi.ajp.2011.11030347. Epub 2011 Oct 31.

Supplemental Content

Support Center